LEFKOFF KYLE Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
4
Insider Buys Sum
$62,697.40
Insider Sells Quantity
20
Insider Sells Sum
$5.15M

Insider Activity of LEFKOFF KYLE

Biography of LEFKOFF KYLE

No biography is available at this moment.

2019-02-06SaleArray Technologies, Inc.
ARRY
director
35,000
0.0707%
$20.60$721,074
2018-07-06SaleArray Technologies, Inc.
ARRY
director
50,000
0.0856%
$17.45$872,500
2018-02-09SaleArray Technologies, Inc.
ARRY
director
50,000
0.0834%
$17.01$850,500
2017-09-29SaleArray Technologies, Inc.
ARRY
director
38,865
0.0469%
$12.31$478,428
2017-03-31SaleArray Technologies, Inc.
ARRY
director
45,000
0.0394%
$8.92$401,400
2017-03-10SaleViridian Therapeutics, Inc.
VRDN
director
3,300
0.0293%
$14.31$47,229-33.81%
2017-03-09SaleViridian Therapeutics, Inc.
VRDN
director
2,500
0.0219%
$14.38$35,962-34.81%
2017-03-08SaleViridian Therapeutics, Inc.
VRDN
director
5,000
0.0454%
$14.70$73,514-33.86%
2017-03-06SaleViridian Therapeutics, Inc.
VRDN
director
10,000
0.0879%
$15.75$157,463-40.06%
2017-02-28SaleViridian Therapeutics, Inc.
VRDN
director
2,258
0.0202%
$13.54$30,580-28.49%
2017-02-27SaleViridian Therapeutics, Inc.
VRDN
director
1,500
0.0128%
$13.79$20,687-32.65%
2017-02-24SaleViridian Therapeutics, Inc.
VRDN
director
6,500
0.0564%
$14.04$91,252-32.67%
2017-02-23SaleViridian Therapeutics, Inc.
VRDN
director
1,800
0.0152%
$13.65$24,566-32.67%
2017-02-22SaleViridian Therapeutics, Inc.
VRDN
director
4,102
0.0363%
$14.36$58,886-32.88%
2015-03-03SaleArray Technologies, Inc.
ARRY
director
70,000
0.0549%
$8.00$560,070
2011-08-11PurchaseArray Technologies, Inc.
ARRY
director
5,000
0.0011%
$2.22$11,100
2010-11-18SaleArray Technologies, Inc.
ARRY
director
2,000
0.0006%
$3.17$6,340
2010-11-17SaleArray Technologies, Inc.
ARRY
director
3,000
0.001%
$3.28$9,840
2010-11-16SaleArray Technologies, Inc.
ARRY
director
5,000
0.0016%
$3.31$16,550
2010-05-07PurchaseArray Technologies, Inc.
ARRY
director
4,000
0.0015%
$3.71$14,840
Total: 24
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.